Page 97 - Contract Development News Today

16 marzo 2021 09:33 Fonte: Adnkronos #chimica-e-farmacia SHANGHAI and DUNDALK, Ireland, March 16, 2021 /PRNewswire/ -- WuXi Vaccines, a world-leading vaccine Contract Development and Manufacturing Organization (CDMO), today announced it achieved the weather-tight construction milestone of its vaccine manufacturing facility currently under construction in Dundalk, Ireland, while the company demonstrated extraordinary resilience despite COVID-19 challenges. The facility is expected to ...

WuXi Vaccines Achieves Weather-Tight Construction Milestone on Main Building of Manufacturing Facility Despite COVID-19 SHANGHAI and DUNDALK, Ireland, March 16, 2021 /PRNewswire/ -- WuXi Vaccines, a world-leading vaccine Contract Development and Manufacturing Organization (CDMO), today announced it achieved the weather-tight construction milestone of its vaccine manufacturing facility currently under construction in Dundalk, Ireland, while the company demonstrated extraordinary resilience despi...

Eden Biologics announces Dr Scott Liu as a member of the Board. He retired from Shanghai Henlius Biotech which he co-founded and has a valuation of over HK$20B.

Published: Mar 15, 2021 Indiana-based radiopharmaceutical Contract Development and Manufacturing Organization expands nuclear pharmacy capabilities with second location   SpectronRx, a leading radiopharmaceutical contract development and manufacturing organization (CDMO), announced today that the U.S. Nuclear Regulatory Commission (NRC) has issued a Materials License for its new Indianapolis, IN headquarters. The license also expands SpectronRx’s roster of authorized nuclear pharmacist...

Share this article Share this article PALM BEACH, Fla., March 15, 2021 /PRNewswire/ -- The recent pandemic, in one way, is like the WWIII we were hoping would never come. The whole world is fighting…  not against each other, but against a common enemy. Never has there been a conflict where all nations are seeking to win, and where industry and governments are rising to the challenge. Billions of dollars and man hours are all focused on creating the atom bomb that can end this war, once and f...

/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and...

Published: Mar 11, 2021 By Alex Keown Saniona, a rare disease-focused company based in Sweden, received feedback from the U.S. Food and Drug Administration (FDA) on a path forward for its hypothalamic obesity (HO) drug Tesomet. Based on guidance from the regulatory agency, Saniona is planning a Phase IIb study in this indication in the first half of this year. “There is currently no medicine approved for hypothalamic obesity, a rare disease secondary to hypothalamic injury, characteri...

Regulatory News: Eurofins (Paris:ERF): empowerDX, a Eurofins subsidiary, announced the launch of its direct-to-consumer, FDA-emergency use authorised, COVID-19 Home Collection Kit on Amazon.

Pharmaceutical Contract Development and Manufacturing Market worth $146.1 billion by 2025 - Exclusive Report by MarketsandMarkets "Pharmaceutical Contract Development and Manufacturing Market (Pharmaceutical, Biologics, Active Pharma ingredients, tablet, Parenteral, Oral Liquid, Semi-Solids), End User (Big Pharma, Small Pharma, Generic Pharma,CRO)-Global Forecast to 2025", published by MarketsandMarkets, the global Pharmaceutical Contract Manufacturing Market is projected to reach USD 146.1 bi...

Source: Media Outreach Additional company office in the Asia Pacific region will showcase Vetter’s expertise and help build and strengthen its business network in China New office underscores importance of Chinese market Physical presence promotes development of new business in China Comprehensive service portfolio supports domestic companies in accessing the global market place SHANGHAI, CHINA AND RAVENSBURG, GERMANY – Media OutReach – 8 March 2021 – Vetter, one of the global lead...